A case with ıncontinentia pigmenti and laser photocoagulation treatment

Objective & Hypothesis:We were determined an optic atrophy in right eye and ischemic areas and superotemporal neovacularization of the left eye at the result of the eye examination in a 9 year-old girl patient who referred with diagnosis of incontinentia pigmenti(IP) to the our eye clinic.

📊

Key Findings & Data:Two seance laser photocoagulation was applied to the ischemic areas and neovascularization lesions according to results of fundus fluorescein angiography(FFA).

💡

Conclusion & Impact:In fundus fluorescein angiography that was taken as a results of treatment were seen minimal leakage and regression in neovascularization.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

We were determined an optic atrophy in right eye and ischemic areas and superotemporal neovacularization of the left eye at the result of the eye examination in a 9 year-old girl patient who referred with diagnosis of incontinentia pigmenti(IP) to the our eye clinic. Two seance laser photocoagulation was applied to the ischemic areas and neovascularization lesions according to results of fundus fluorescein angiography(FFA). In fundus fluorescein angiography that was taken as a results of treatment were seen minimal leakage and regression in neovascularization.

Özet

Kliniğimize İnkontinensiya Pigmenti(IP) tanısı ile başvuran 9 yaşında bayan hastanın yapılan muayenesinde sağda optik atrofi, solda temporal üst yarıda iskemik alanlar ve yeni damar oluşumları saptandı. Hastanın çekilen fundus floresein anjiografisine göre iskemik alanlara ve damarsal alanın etrafına iki seans laser fotokoagülasyon uygulandı. Tedavi sonucunda çekilen fundus fluoresein anjiografisinde (FFA) yeni damar oluşumunda gerileme ve minimal sızıntı izlendi.

🔖

Cite This Article

GÖK, K., AKBAŞ, U., ÜNSAL, N., KAPRAN, Z., ALTAN, T. (2022). A case with ıncontinentia pigmenti and laser photocoagulation treatment. Türk Oftalmoloji Dergisi, Cilt: 39 - Sayı: 1, 56–59. https://ajindex.com/articles/638517

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Carney RG: Incontinentia pigmenti: a world statistical analysis. Arch Dermatol 1976; 112:535-42. 2.Lever, W. F: Histopathology of the Skin. Philadelphia, J.B. Lippincott, 1967, p. 86. 3.Carney, R. G: Incontinentia pigmenti. Arch. Dermatol. 64:126^1951. 4.Garrod, A. E: Peculiar pigmentation of the skin. Trans. Clin. Soc. 39:216,1906. 5.Bloch B: Eigentiimliche, bisher nicht beschriebene pig mentaffektion (IP). Schweiz Med Wochenschr 1926;7:404-5. 6.Sulzberger MB: Über eine bisher nicht beschriebene congenitale pigmentanomalie (IP). Arch Dermatol Syph (Berlin) 1928; 154:19-32. 7.Sulzberger, M.B.: Incontinentia pigmenti (Bloch-Sulzberger): Arch. Dermatol. Syph. 1938;38:57. 8.Jones, S.T.: Retrolental membrane associated with Bloch-Sulzberger syndrome (Incontinentia pigmenti). Am. J. Ophthalmol. 1966;62:330. 9.Miller, R.J., and Anderson, R.E.: A retrolental mass in in continentia pigmenti. Survey Ophthalmol. 1966; 11:41. 10.Cole, J.G., and Cole, H.G.: Incontinentia pigmenti. Am. J. Ophthalmol. 1959;47:321. 11.Scott, J.G., Friedemann, A.I., Chitters, M., and Pepler, W. J.: Ocular changes in the Bloch-Sulzberger syndrome (in-continentia pigmenti). Br. J. Ophthalmol. 1955;39:276. 12.Fiscbein, F.I., Schub, M., and Lesko, W.S.: Incontinentia pigmenti, pheochromocytoma, and ocular abnormalities. Am. J. Ophthalmol. 1972;73:961. 13.Findlay, G.H.: On the pathogenesis of incontinentia pigmenti. Br. J Dermatol. 1952;64:141. 14.Watzke, R.C., Stevens, T. S., and Carney, R.G., Jr.: Retinel vascular hypoplasia and telengiectasia associated with incontinentia pigmenti. Read before the Association for Research in Vision and Ophthalmology meeting, Saraso-ta, Florida, April 25,1974. 15.Zweifach, P.H.: Incontinentia pigmenti. Its association with retinal dysplazi. Am. J. Ophthalmol. 1966;62:716. 16.Jensen, V.A.: Incontinentia pigmenti (Bloch-Sulzberger) associated with prolife'rative eyeground changes and positive toxoplasmosis reaction. Acta Psychiatr. (Scand.) 31(Suppl. 108): 197,1956. 17.The International Incontinentia Pigmenti (IP) Consortium. Genomic rearrangement in NEMO impairs NF-xB activation and a cause of incontinentia pigmenti. Nature 200;405:466-72. 18.Wieacker P, Zimmer J, Ropers HH: X-inactivation patterns in two syndromes with probable X-linked dominant, male lethal inheritance. Clin Genet 1985;28:238-42. 19.Migeon BR, Axelman J, Juan de Beur S, et al: Selection against lethal alleles in females heterozygous for incontinentia pigmenti. Am J Hum Genet 1989;44:10